V
VitreoRetinal Surgery | Edina, MN
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Ranibizumab
Lampalizumab
ranibizumab
RGX-314
bevacizumab
Faricimab
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 12 total trials
This is a prospective study designed to evaluate the long-term safety and efficacy of ABBV-RGX-314. Eligible participants are those who were previous...
Invitation-only
Neovascular Age-Related Macular Degeneration (nAMD)
Drug: Standard of Care
Drug: Ranibizumab
This is a first in-human study to investigate the safety, tolerability and efficacy of zifibancimig administered through intravitreal (IVT) injection...
Active, not recruiting
Macular Degeneration
Drug: Ranibizumab
Drug: Zifibancimig
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems